Webinar: Exploiting digital histology approaches to probe the pathophysiology of SARS-CoV-2 infection
JOIN THE LIVE WEBINAR
Date and time : June 2, 2021 at 11:00am (EDT)/5:00pm (CET)
Exploiting digital histology approaches to probe the pathophysiology of SARS-CoV-2 infection
COVID-19 is a complex multi-phase disease. In most people an early innate immune response transitions into a broadly effective adaptive immune response that controls the virus. However, 20-30% of symptomatic patients require hospitalisation, with ICU admission rates ranging from 4.9-11.5%, and overall fatality rates of around 0.5%.
Long-term inflammation in patients receiving supportive care in ICU can lead to pulmonary fibrosis, representing a third phase of the disease.
Join this live webinar to learn how to:
- Describe different techniques involved in molecular histology and how they integrate in a workflow.
- Identify the pathophysiology of SARS-CoV-2 infection in tissues, including related to viral replication and anti-viral immunity.
- Demonstrate how digital image analyses (immunofluorescence, transcriptomic) can be utilised to determine features of microenvironmental immunity.
Speakers
Kelly Hunter – BSc Biochemistry, MSc
Genomics Medicine
Digital Pathology Analyst, Molecular
Histology Facility, University of Birmingham
Dr Graham S. Taylor – BSc, PhD
Senior Lecturer, University of Birmingham
Source: Lecia Biosystems
